New York, NY & Mainz, DE…Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the submission of new data to the U.S. Food and Drug Administration (FDA) demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators. The data have been submitted to the FDA to support a proposed update to the U.S. Emergency Use Authorization (EUA) Prescribing Information, which would allow for vaccine vials to be stored at these temperatures for a total of two weeks as an alternative or complement to storage in an ultra-low temperature freezer. The FDA submission includes stability da
Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature )
Also on site :